APA (7th ed.) Citation

Tchao, N., Sarkar, N., Hu, X., Zhang, R., Milmont, C., Shi Jin, Y., . . . Stanley, C. (2022). PO.6.127 Efavaleukin alfa, a novel IL-2 mutein, selectively expands regulatory t cells in patients with SLE: Final results of a phase 1b multiple ascending dose study. Lupus science & medicine, 9(Suppl 2), A96-A97. https://doi.org/10.1136/lupus-2022-elm2022.148

Chicago Style (17th ed.) Citation

Tchao, N., et al. "PO.6.127 Efavaleukin Alfa, a Novel IL-2 Mutein, Selectively Expands Regulatory T Cells in Patients with SLE: Final Results of a Phase 1b Multiple Ascending Dose Study." Lupus Science & Medicine 9, no. Suppl 2 (2022): A96-A97. https://doi.org/10.1136/lupus-2022-elm2022.148.

MLA (9th ed.) Citation

Tchao, N., et al. "PO.6.127 Efavaleukin Alfa, a Novel IL-2 Mutein, Selectively Expands Regulatory T Cells in Patients with SLE: Final Results of a Phase 1b Multiple Ascending Dose Study." Lupus Science & Medicine, vol. 9, no. Suppl 2, 2022, pp. A96-A97, https://doi.org/10.1136/lupus-2022-elm2022.148.